• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过拓扑结构推断通路活性以进行精确的生存结果预测:以乳腺癌为例

Topologically inferring pathway activity for precise survival outcome prediction: breast cancer as a case.

作者信息

Liu Wei, Wang Wei, Tian Guohua, Xie Wenming, Lei Li, Liu Jiujin, Huang Wanxun, Xu Liyan, Li Enmin

机构信息

The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou, 515041, China.

Department of Mathematics, Heilongjiang Institute of Technology, Harbin, 150050, China.

出版信息

Mol Biosyst. 2017 Feb 28;13(3):537-548. doi: 10.1039/c6mb00757k.

DOI:10.1039/c6mb00757k
PMID:28098303
Abstract

Accurately predicting the survival outcome of patients is of great importance in clinical cancer research. In the past decade, building survival prediction models based on gene expression data has received increasing interest. However, the existing methods are mainly based on individual gene signatures, which are known to have limited prediction accuracy on independent datasets and unclear biological relevance. Here, we propose a novel pathway-based survival prediction method called DRWPSurv in order to accurately predict survival outcome. DRWPSurv integrates gene expression profiles and prior gene interaction information to topologically infer survival associated pathway activities, and uses the pathway activities as features to construct Lasso-Cox model. It uses topological importance of genes evaluated by directed random walk to enhance the robustness of pathway activities and thereby improve the predictive performance. We applied DRWPSurv on three independent breast cancer datasets and compared the predictive performance with a traditional gene-based method and four pathway-based methods. Results showed that pathway-based methods obtained comparable or better predictive performance than the gene-based method, whereas DRWPSurv could predict survival outcome with better accuracy and robustness among the pathway-based methods. In addition, the risk pathways identified by DRWPSurv provide biologically informative models for breast cancer prognosis and treatment.

摘要

在临床癌症研究中,准确预测患者的生存结果至关重要。在过去十年中,基于基因表达数据构建生存预测模型受到了越来越多的关注。然而,现有方法主要基于单个基因特征,已知其在独立数据集上的预测准确性有限且生物学相关性不明确。在此,我们提出一种名为DRWPSurv的基于通路的新型生存预测方法,以便准确预测生存结果。DRWPSurv整合基因表达谱和先前的基因相互作用信息,以拓扑方式推断与生存相关的通路活性,并将通路活性用作特征来构建套索 - 考克斯模型。它使用通过有向随机游走评估的基因拓扑重要性来增强通路活性的稳健性,从而提高预测性能。我们将DRWPSurv应用于三个独立的乳腺癌数据集,并将预测性能与传统的基于基因的方法和四种基于通路的方法进行比较。结果表明,基于通路的方法比基于基因的方法获得了相当或更好的预测性能,而在基于通路的方法中,DRWPSurv能够以更高的准确性和稳健性预测生存结果。此外,DRWPSurv识别出的风险通路为乳腺癌的预后和治疗提供了具有生物学信息的模型。

相似文献

1
Topologically inferring pathway activity for precise survival outcome prediction: breast cancer as a case.通过拓扑结构推断通路活性以进行精确的生存结果预测:以乳腺癌为例
Mol Biosyst. 2017 Feb 28;13(3):537-548. doi: 10.1039/c6mb00757k.
2
Mixture classification model based on clinical markers for breast cancer prognosis.基于临床标志物的乳腺癌预后混合分类模型。
Artif Intell Med. 2010 Feb-Mar;48(2-3):129-37. doi: 10.1016/j.artmed.2009.07.008. Epub 2009 Dec 14.
3
Incorporating topological information for predicting robust cancer subnetwork markers in human protein-protein interaction network.整合拓扑信息以预测人类蛋白质-蛋白质相互作用网络中稳健的癌症子网标志物。
BMC Bioinformatics. 2016 Oct 6;17(Suppl 13):351. doi: 10.1186/s12859-016-1224-1.
4
Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case.通过整合基因组和代谢组数据进行拓扑学推断通路活性以实现精确的癌症分类:以前列腺癌为例
Sci Rep. 2015 Aug 19;5:13192. doi: 10.1038/srep13192.
5
Integrative pathway-based survival prediction utilizing the interaction between gene expression and DNA methylation in breast cancer.基于整合通路的生存预测方法,利用乳腺癌中基因表达与 DNA 甲基化的相互作用。
BMC Med Genomics. 2018 Sep 14;11(Suppl 3):68. doi: 10.1186/s12920-018-0389-z.
6
Integration of pathway structure information into a reweighted partial Cox regression approach for survival analysis on high-dimensional gene expression data.将通路结构信息整合到一种重新加权的偏Cox回归方法中,用于对高维基因表达数据进行生存分析。
Mol Biosyst. 2015 Jul;11(7):1876-86. doi: 10.1039/c5mb00044k.
7
Topologically inferring risk-active pathways toward precise cancer classification by directed random walk.通过有向随机游走拓扑推断风险活跃途径以实现精确的癌症分类。
Bioinformatics. 2013 Sep 1;29(17):2169-77. doi: 10.1093/bioinformatics/btt373. Epub 2013 Jul 10.
8
Identification of hub subnetwork based on topological features of genes in breast cancer.基于乳腺癌基因拓扑特征的枢纽子网鉴定
Int J Mol Med. 2015 Mar;35(3):664-74. doi: 10.3892/ijmm.2014.2057. Epub 2014 Dec 30.
9
Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.对公共癌症数据集和特征的评估确定了具有强大预后和预测价值的TP53突变特征。
BMC Cancer. 2015 Mar 26;15:179. doi: 10.1186/s12885-015-1102-7.
10
BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency.BMRF-MI:通过对基因依赖性进行建模来综合识别蛋白质相互作用网络。
BMC Genomics. 2015;16 Suppl 7(Suppl 7):S10. doi: 10.1186/1471-2164-16-S7-S10. Epub 2015 Jun 11.

引用本文的文献

1
Construct prognostic models of multiple myeloma with pathway information incorporated.构建包含通路信息的多发性骨髓瘤预后模型。
PLoS Comput Biol. 2024 Sep 10;20(9):e1012444. doi: 10.1371/journal.pcbi.1012444. eCollection 2024 Sep.
2
Enhanced Directed Random Walk for the Identification of Breast Cancer Prognostic Markers from Multiclass Expression Data.用于从多类表达数据中识别乳腺癌预后标志物的增强定向随机游走算法
Entropy (Basel). 2021 Sep 20;23(9):1232. doi: 10.3390/e23091232.
3
Integration of gene interaction information into a reweighted random survival forest approach for accurate survival prediction and survival biomarker discovery.
将基因交互信息整合到重新加权的随机生存森林方法中,以实现准确的生存预测和生存生物标志物发现。
Sci Rep. 2018 Sep 4;8(1):13202. doi: 10.1038/s41598-018-31497-0.
4
Estimating the survival advantage based on telomere length and serum biomarkers of aging.基于端粒长度和衰老血清生物标志物评估生存优势。
J Transl Med. 2017 Aug 1;15(1):166. doi: 10.1186/s12967-017-1267-8.